Latest Breaking News On - Vivos therapeutics - Page 5 : comparemela.com

VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips VVOS stock results show that Vivos Therapeutics missed analyst estimates for earnings per share…

Market newsStock adviceVivos therapeuticsVivos therapeutics missesMisses revenueReaking news

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesEast north africaKirk huntsmanJulie gannonSecurities exchangeDrug administrationEnvista holdings corporationAirway repositioningVivos institute in denverVivos therapeutics incExchange commissionPositive business momentumSales pipeline growth followingVivo proprietary oral medical devicesTreat severe obstructive sleep

Vivos Therapeutics Announces Exercise of Warrants for Approximately $4 0 Million Aggregate Gross Proceeds

LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device.

United statesJulie gannonExchange commissionA gp alliance global partnersVivos therapeutics incSecurities exchangeAlliance global partnersSecurities actVivos therapeuticsVivos methodApnea hypopnea indexVivos integrated practiceSecurities exchange actInvestor relationsMedia contact

Vivos Therapeutics sees gross proceeds of $4M from exercise of warrant

Vivos Therapeutics sees gross proceeds of $4M from exercise of warrant
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Vivos therapeutics

Vivos Therapeutics sees opportunities for its FDA-approved oral sleep apnea treatment

Vivos Therapeutics sees opportunities for its FDA-approved oral sleep apnea treatment
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Philips respironicPhilips respironicsKirk huntsmanDrug administrationUnitedhealth group incVivos therapeutics